Glenmark received approval to launch apremilast from the Drug Controller General of India after conducting clinical trials on psoriasis patients for 16 weeks
Source URL: Glenmark to unveil oral drug to treat psoriasis
Source Website: Livemint.com (http://www.livemint.com/rss/industry)